Cargando…

The efficacy of cisplatin on nasopharyngeal carcinoma cells may be increased via the downregulation of fibroblast growth factor receptor 2

Cisplatin is one of the primary compounds used in the treatment of nasopharyngeal carcinoma (NPC), and fibroblast growth factor receptor 2 (FGFR2) has emerged to be a promising target for treatment in various tumors. Therefore, the present study aimed to explore whether the expression levels of FGFR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pu, Li, Su, Lizhong, Kang, Xixun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559331/ https://www.ncbi.nlm.nih.gov/pubmed/31115494 http://dx.doi.org/10.3892/ijmm.2019.4193

Ejemplares similares

Downregulation of FoxM1 sensitizes nasopharyngeal carcinoma cells to cisplatin via inhibition of MRN-ATM-mediated DNA repair
por: Li, Dandan, et al.
Publicado: (2019)

MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma
por: Bissey, Pierre-Antoine, et al.
Publicado: (2020)

METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE
por: Li, Ruyi, et al.
Publicado: (2021)

(Pro)renin Receptor Regulates Phosphate Homeostasis in Rats via Releasing Fibroblast Growth Factor-23
por: Lu, Aihua, et al.
Publicado: (2022)

Downregulation of LINC01857 Increases Sensitivity of Gastric Carcinoma Cells to Cisplatin
por: Chen, Yun, et al.
Publicado: (2022)

Downregulation of ribophorin II suppresses tumor growth, migration, and invasion of nasopharyngeal carcinoma
por: Hong, Feilong, et al.
Publicado: (2018)

Gap Junction Enhancer Increases Efficacy of Cisplatin to Attenuate Mammary Tumor Growth
por: Shishido, Stephanie N., et al.
Publicado: (2012)

Retracted: Downregulation of LINC01857 Increases Sensitivity of Gastric Carcinoma Cells to Cisplatin
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts
por: Cao, Long-Hui, et al.
Publicado: (2016)

Fibroblast growth factor 21 is related to cisplatin resistance in ovarian cancer
por: Zhong, Qian, et al.
Publicado: (2022)

Leucopenia and treatment efficacy in advanced nasopharyngeal carcinoma
por: Su, Zhen, et al.
Publicado: (2015)

Inhibition of PI3K/mTOR increased the sensitivity of hepatocellular carcinoma cells to cisplatin via interference with mitochondrial‐lysosomal crosstalk
por: Sheng, Jiyao, et al.
Publicado: (2019)

Downregulation of CR6-interacting factor 1 suppresses keloid fibroblast growth via the TGF-β/Smad signaling pathway
por: Nagar, Harsha, et al.
Publicado: (2021)

Downregulation of Ribophorin II Suppresses Tumor Growth, Migration, and Invasion of Nasopharyngeal Carcinoma [Retraction]
Publicado: (2023)

Efficacy of Cetuximab in Nasopharyngeal Carcinoma Patients Receiving Concurrent Cisplatin-Radiotherapy: A Meta-Analysis
por: Wang, Lin, et al.
Publicado: (2022)

Targeting fatty acid synthase sensitizes human nasopharyngeal carcinoma cells to radiation via downregulating frizzled class receptor 10
por: Chen, Jiongyu, et al.
Publicado: (2020)

The efficacy and safety of apatinib in patients with recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis
por: Lin, Huixiong, et al.
Publicado: (2022)

[Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins
por: Račkauskas, Rokas, et al.
Publicado: (2023)

BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer
por: Kuang, Chun-mei, et al.
Publicado: (2017)

Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma
por: Zhang, Yuan, et al.
Publicado: (2019)

BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma
por: Gao, Wei, et al.
Publicado: (2017)

Comparison Efficacy and Safety of Gemcitabine plus Cisplatin and 5-Fluorouracil plus Cisplatin for Metastatic Nasopharyngeal Carcinoma: A Meta-Analysis and Systematic Review
por: Yan, Le, et al.
Publicado: (2022)

Increased efficacy of gefitinib on cisplatin-resistant wild-type epidermal growth factor receptor non-small cell lung cancer cells
por: Li, Amin, et al.
Publicado: (2020)

Chronic treatment with cisplatin induces replication-dependent sister chromatid recombination to confer cisplatin-resistant phenotype in nasopharyngeal carcinoma
por: Su, Wen-Pin, et al.
Publicado: (2014)

A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma
por: Li, H. M., et al.
Publicado: (2016)

Efficacy and safety of weekly versus triweekly cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma: A meta-analysis
por: Chen, Long, et al.
Publicado: (2022)

Retracted: Efficacy of Cetuximab in Nasopharyngeal Carcinoma Patients Receiving Concurrent Cisplatin-Radiotherapy: A Meta-Analysis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Downregulation of HIPK2 Increases Resistance of Bladder Cancer Cell to Cisplatin by Regulating Wip1
por: Lin, Jun, et al.
Publicado: (2014)

miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9
por: WU, LIN, et al.
Publicado: (2016)

Calcitriol downregulates fibroblast growth factor receptor 1 through histone deacetylase activation in HL-1 atrial myocytes
por: Lee, Ting-Wei, et al.
Publicado: (2018)

Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin
Publicado: (1989)

Mesenchymal stem/stromal cells-derived IL-6 promotes nasopharyngeal carcinoma growth and resistance to cisplatin via upregulating CD73 expression
por: Zeng, Jincheng, et al.
Publicado: (2020)

Baicalin reverses radioresistance in nasopharyngeal carcinoma by downregulating autophagy
por: Wang, Cong, et al.
Publicado: (2020)

Fibroblasts in metastatic lymph nodes confer cisplatin resistance to ESCC tumor cells via PI16
por: Liang, Lily, et al.
Publicado: (2023)

Skin Aging-Dependent Activation of the PI3K Signaling Pathway via Downregulation of PTEN Increases Intracellular ROS in Human Dermal Fibroblasts
por: Noh, Eun-Mi, et al.
Publicado: (2016)

MicroRNA-765 sensitizes osteosarcoma cells to cisplatin via downregulating APE1 expression
por: Liang, Wei, et al.
Publicado: (2019)

Atorvastatin potentiates the chemosensitivity of human liver cancer cells to cisplatin via downregulating YAP1
por: Guo, Liwen, et al.
Publicado: (2021)

MiR-7-5p suppresses invasion via downregulation of the autophagy-related gene ATG7 and increases chemoresistance to cisplatin in BCa
por: Wang, Chong, et al.
Publicado: (2022)

Gemcitabine and cisplatin regimen facilitates prognosis of advanced nasopharyngeal carcinoma
por: Li, Qiongxuan, et al.
Publicado: (2018)

Comparing the efficacy and safety of cisplatin and other platinum-based chemotherapies in locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis
por: Li, Zhiru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uh4tbd2chufhn8c13hafu21rta